This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Abivax, Centre National De La Recherche Scientifique, Institut Curie. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 39 
1 out of 132 
1 out of 162 
Years Active: 2026
Title: Natacha Bienvenu: Innovator in RNA Virus Treatment
Introduction: Natacha Bienvenu is a notable inventor based in Toulouse, France. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds for treating RNA virus infections. Although she currently holds no granted patents, her work is recognized for its potential impact on medical science.
Latest Patent Applications: Natacha Bienvenu's patent application titled "Aryl-N-Aryl Derivatives for Treating a RNA Virus Infection" describes a compound of formula (I). This compound includes various functional groups, such as a —CO—NR— group, a —NR′—CO— group, and a heterocyclyl, which is a 5- or 6-membered ring containing heteroatoms like O, S, and/or N. The application outlines the potential of these compounds in providing therapeutic solutions for RNA virus infections.
Conclusion: Natacha Bienvenu's innovative research and patent application highlight her commitment to advancing medical treatments for viral infections. Her work continues to inspire future developments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile